Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Melanoma

  Free Subscription


21.01.2019

1 Ann Surg Oncol
2 Biochem Biophys Res Commun
1 BMC Cancer
1 Cancer Lett
1 Cancer Res
2 Clin Cancer Res
1 Int J Cancer
1 J Am Acad Dermatol
2 J Surg Oncol
1 Melanoma Res
2 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg Oncol

  1. TRINH BB, Kounalakis N
    ASO Author Reflections: Impact of SPECT/CT on Sentinel Lymph Node Biopsy in Head and Neck Melanoma.
    Ann Surg Oncol. 2019 Jan 11. pii: 10.1245/s10434-018-6955.
    PubMed     Text format    


    Biochem Biophys Res Commun

  2. JOURDAIN M, Melly S, Summermatter S, Hatakeyama S, et al
    Mouse models of cancer-induced cachexia: Hind limb muscle mass and evoked force as readouts.
    Biochem Biophys Res Commun. 2018;503:2415-2420.
    PubMed     Text format     Abstract available

  3. KIM KI, Jo JW, Lee JH, Kim CD, et al
    Induction of pigmentation by a small molecule tyrosine kinase inhibitor nilotinib.
    Biochem Biophys Res Commun. 2018;503:2271-2276.
    PubMed     Text format     Abstract available


    BMC Cancer

  4. SONG X, Guo C, Zheng Y, Wang Y, et al
    Post-transcriptional regulation of cancer/testis antigen MAGEC2 expression by TRIM28 in tumor cells.
    BMC Cancer. 2018;18:971.
    PubMed     Text format     Abstract available


    Cancer Lett

  5. BIANCHINI F, Portioli E, Ferlenghi F, Vacondio F, et al
    Cell-targeted c(AmpRGD)-sunitinib molecular conjugates impair tumor growth of melanoma.
    Cancer Lett. 2019 Jan 10. pii: S0304-3835(19)30012.
    PubMed     Text format     Abstract available


    Cancer Res

  6. TAYLOR A, Rothstein D, Rudd CE
    Small-Molecule Inhibition of PD-1 Transcription Is an Effective Alternative to Antibody Blockade in Cancer Therapy.
    Cancer Res. 2018;78:706-717.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  7. GARTRELL RD, Marks DK, Rizk EM, Bogardus M, et al
    Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II-III Melanoma.
    Clin Cancer Res. 2019 Jan 15. pii: 1078-0432.CCR-18-2847.
    PubMed     Text format     Abstract available

  8. PIRES DA SILVA I, Wang KYX, Wilmott JS, Holst J, et al
    Distinct Molecular Profiles and Immunotherapy Treatment Outcomes of V600E and V600K BRAF-Mutant Melanoma.
    Clin Cancer Res. 2019 Jan 10. pii: 1078-0432.CCR-18-1680.
    PubMed     Text format     Abstract available


    Int J Cancer

  9. MAEDA T, Hayashi T, Furukawa H, Iwasaki D, et al
    Immune-mediated antitumor effect of a transplanted lymph node.
    Int J Cancer. 2018;143:1224-1235.
    PubMed     Text format     Abstract available


    J Am Acad Dermatol

  10. LI WQ, Cho E, Weinstock MA, Li S, et al
    Cutaneous nevi and risk of melanoma death in women and men: a prospective study.
    J Am Acad Dermatol. 2019 Jan 10. pii: S0190-9622(19)30064.
    PubMed     Text format     Abstract available


    J Surg Oncol

  11. READ T, Fayers W, Thomas J, Wagels M, et al
    Patients with in-transit melanoma metastases have comparable survival outcomes following isolated limb infusion or intralesional PV-10-A propensity score matched, single center study.
    J Surg Oncol. 2019 Jan 15. doi: 10.1002/jso.25373.
    PubMed     Text format     Abstract available

  12. BRADY MS
    Introduction: Melanoma seminar.
    J Surg Oncol. 2019;119:167.
    PubMed     Text format    


    Melanoma Res

  13. PAN B, Lin X, Zhang L, Hong W, et al
    Long noncoding RNA X-inactive specific transcript promotes malignant melanoma progression and oxaliplatin resistance.
    Melanoma Res. 2019 Jan 11. doi: 10.1097/CMR.0000000000000560.
    PubMed     Text format     Abstract available


    PLoS One

  14. HUGDAHL E, Bachmann IM, Schuster C, Ladstein RG, et al
    Prognostic value of uPAR expression and angiogenesis in primary and metastatic melanoma.
    PLoS One. 2019;14:e0210399.
    PubMed     Text format     Abstract available

  15. BALERMPAS P, Stera S, Muller von der Grun J, Loutfi-Krauss B, et al
    Repeated in-field radiosurgery for locally recurrent brain metastases: Feasibility, results and survival in a heavily treated patient cohort.
    PLoS One. 2018;13:e0198692.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  16. BLANDO J, Sharma A, Higa MG, Zhao H, et al
    Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer.
    Proc Natl Acad Sci U S A. 2019 Jan 11. pii: 1811067116.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: